4-Desoxymescaline, or 4-methyl-3,5-dimethoxyphenethylamine, is a
mescaline analogue related to other
psychedelic phenethylamines. It is commonly referred to as DESOXY. DESOXY was discovered by
Alexander Shulgin and published in his book ''
PiHKAL''.
Effects
The effects of DESOXY vary significantly from
mescaline, despite their chemical similarity.
Dosage
A typical dosage is within the range of 40–120 mg and lasts 6–8 hours.
Legality
In 1970 the
Controlled Substances Act placed
mescaline into
Schedule I in the
United States
The United States of America (U.S.A. or USA), commonly known as the United States (U.S. or US) or America, is a country primarily located in North America. It consists of 50 states, a federal district, five major unincorporated territori ...
. It is similarly controlled in other nations. Depending on whether or not it is intended for human consumption, 4-desoxymescaline could be considered an
analogue of
mescaline, under the
Federal Analogue Act
The Federal Analogue Act, , is a section of the United States Controlled Substances Act passed in 1986 which allows any chemical "substantially similar" to a controlled substance listed in Schedule I or II to be treated as if it were listed in ...
and similar bills in other countries, making it illegal to manufacture, buy, possess, or distribute without a DEA or related license.
DESOXY is also an isomer of
2C-D
2C-D (2,5-dimethoxy-4-methylphenethylamine or 2C-M) is a psychedelic drug of the 2C family that is sometimes used as an entheogen. It was first synthesized in 1970 by a team from the Texas Research Institute of Mental Sciences, and its activity w ...
which makes it a schedule 1 drug in the United States.
References
External links
*
Alexander Shulgin, Jacob, P
Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs NIDA Research Monograph 146 (Hallucinogens: An Update), 1994.
{{Phenethylamines
Psychedelic phenethylamines
Mescalines